Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
bioMérieux Korea, Seoul, Korea.
Ann Lab Med. 2022 May 1;42(3):352-357. doi: 10.3343/alm.2022.42.3.352.
von Hippel-Lindau (VHL) disease is an autosomal dominant disorder caused by variants of the VHL tumor suppressor gene (). Early detection and treatment are essential to prevent morbidity and mortality. We evaluated the effectiveness of surveillance strategies and the utility of a VHL clinic with a multidisciplinary team for the first time in Korea.
The VHL clinic was organized at the Samsung Medical Center in 2011 and consisted of a multidisciplinary team, including an endocrinologist, urologist, general surgeon, neurosurgeon, ophthalmologist, otolaryngologist, and radiologist. Biochemical and imaging surveillance and personalized genetic counseling were conducted at the VHL clinic and patients were referred to the necessary departments upon detection of disease manifestation. We divided the patients in three groups (I-III) based on their compliance to VHL clinic attendance.
Between 2011 and 2018, 50 VHL patients were identified by molecular analysis and referred to the VHL clinic. Most patients regularly participated in imaging of the central nervous system (43/50, 86.0%) and of the abdomen (46/50, 92.0%). However, there were differences in compliance to determination of the catecholamine level, audiometry, and ophthalmic examination among the three groups.
We present the results of using a multidisciplinary team approach and showed that the VHL clinic strategy is useful for the comprehensive surveillance and management of VHL disease. We hope that VHL clinics will be widely set up in hospitals to improve prognosis in patients with VHL.
von Hippel-Lindau(VHL)病是一种常染色体显性遗传疾病,由 VHL 肿瘤抑制基因()的变异引起。早期发现和治疗对于预防发病率和死亡率至关重要。我们首次在韩国评估了监测策略的有效性和多学科团队 VHL 诊所的实用性。
VHL 诊所于 2011 年在三星医疗中心成立,由内分泌学家、泌尿科医生、普通外科医生、神经外科医生、眼科医生、耳鼻喉科医生和放射科医生组成的多学科团队组成。在 VHL 诊所进行生化和影像学监测以及个性化基因咨询,并在发现疾病表现时将患者转介到必要的科室。我们根据患者对 VHL 诊所就诊的依从性将患者分为三组(I-III 组)。
2011 年至 2018 年间,通过分子分析鉴定了 50 名 VHL 患者,并将其转介至 VHL 诊所。大多数患者定期接受中枢神经系统(43/50,86.0%)和腹部(46/50,92.0%)的影像学检查。然而,三组患者在测定儿茶酚胺水平、听力测试和眼科检查的依从性方面存在差异。
我们介绍了使用多学科团队方法的结果,并表明 VHL 诊所策略对于 VHL 疾病的全面监测和管理是有用的。我们希望在医院广泛设立 VHL 诊所,以改善 VHL 患者的预后。